Pharma Journalist -

Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd., recently announced a $90M investment plan to…
Read More...

AbbVie and Capstan Therapeutics, Inc. announced a definitive agreement under which AbbVie will acquire Capstan, including CPTX2309, a potential first-in-class in vivo tLNP anti-CD19…
Read More...

Takeda announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID ERC, the first and only ready-to-use liquid immunoglobulin (IG) therapy with low…
Read More...

ProFound Therapeutics, a company pioneering the expanded human proteome to develop first-in-class medicines for multiple diseases, today announced a four-year collaboration with…
Read More...

Novartis has officially completed its acquisition of Regulus Therapeutics Inc., solidifying its strategic focus on advancing treatments for renal diseases. With the closing of the deal,…
Read More...

Porton Advanced Solutions, a global leader in cell and gene therapy contract development and manufacturing (CDMO), has signed a Memorandum of Understanding (MOU) with EVA Pharma, a…
Read More...

Bayer and Tsinghua University (THU) announced that they have extended their research collaboration of 16 years by an additional three years, to further accelerate the translation of…
Read More...

GE HealthCare announced that the U.S. Food and Drug Administration (FDA) has approved an updated label for its PET imaging agent Vizamyl™ (flutemetamol F 18 injection), used for…
Read More...

GSK plc has announced that the U.S. Food and Drug Administration (FDA) has approved a 200 mg/mL autoinjector form of Benlysta (belimumab) for subcutaneous injection in pediatric…
Read More...

Gilead Sciences, Inc. and Kymera Therapeutics, Inc. have announced an exclusive option and license agreement aimed at advancing a novel class of cancer treatments: molecular glue…
Read More...